Labiotech.eu

News and Trends 29 Jul 2016

Polish Selvita’s Inflammation Research used to start new Biotech in Scotland

The new Biotech Nodthera will be based in Edinburgh and focus on the discovery and development of novel small molecule candidates to treat inflammation in a range of autoimmune diseases. Founded by Epidarex Capital, it will work alongside Selvita (Poland) in a series of deals worth up to €6.35M. The technology behind Nodthera’s focus is built on […]

July 29, 2016 - 3 minutesmins - By Dani Bancroft

News and Trends 29 Jul 2016

Philogen targets Angiogenesis for cancer and Autoimmune Therapies

Barcelona was pleasant but once again it’s time to go away! We won’t go far… we’re just crossing the Balearic sea to the shores of Italy and visit Sovicille, a suburban town not far from Sienna, where Swiss-Italian company Philogen, our Biotech of the Week, is based! City: Sovicille (Italy) Founded: 1996 Employees: 70 Financial Data: N/A CEO: Duccio […]

July 29, 2016 - 2 minutesmins - By Joachim Eeckhout

News and Trends 28 Jul 2016

World Hepatitis Day 2016: What is the plan for Biotech and Policy Makers?

What is the purpose of the #NoHep campaign? To get rid of the inflammatory Liver viruses which are responsible for killing up to 1.4 million people each year, by 2030. Sometimes also described as the ‘Silent Epidemic’, Hepatitis is the inflammation of the liver, which can be caused by several types of viral infections. Research […]

July 28, 2016 - 2 minutesmins - By Dani Bancroft

selective nanopore sequencing real time ngs

News and Trends 28 Jul 2016

Pocket NGS can now select DNA fragments for faster Sequencing

Researchers from the University of Nottingham have developed a way to select which DNA to sequence with the pocket-sized MinION. The new feature speeds up on-the-spot, real-time DNA sequencing. Developed by the billion-euro Biotech Oxford Nanopore (UK), the small MinION may not have the accuracy and speed of normal laboratory machines for next generation sequencing (NGS). But […]

July 28, 2016 - 3 minutesmins - By Denise Neves Gameiro

taurx tau protein tangles biotech alzheimers

News and Trends 28 Jul 2016

World first Drug to ‘dissolve’ Tau-tangles in Alzheimer’s has Phase III Results

The much-anticipated results of TauRx’s Phase III trial for Alzheimer’s disease have finally been disclosed. Despite some complicated effects, this could be the first available working therapy for Alzheimer’s patients. According to the WHO, Alzheimer’s disease is the cause of up to 70% of dementia cases, which translates to over 30 million patients worldwide. As the world population ages, Alzheimer’s […]

July 28, 2016 - 3 minutesmins - By Denise Neves Gameiro

nootkatone evolva natural mosquito repellant zika

News and Trends 27 Jul 2016

SynBio Nootkatone now in trials to stop the Spread of Zika

The grapefruit aroma nootkatone is now in field trials to assess its effectiveness against mosquitoes that spread the Zika virus. Good news for Evolva, which figured out a SynBio process to produce the compound. Recently, the Zika went from being considered a mild virus to a public health emergency. As the virus was linked with infant microcephaly, there […]

July 27, 2016 - 3 minutesmins - By Denise Neves Gameiro

mrna astrazeneca cardiometabolic diseases moderna

News and Trends 27 Jul 2016

AstraZeneca plans Phase I trial with mRNA therapy for Cardiovascular Disease

The collaboration between AstraZeneca and the money-magnet Moderna is giving its first steps. AstraZeneca is filing for authorization of a German Phase I trial, to assess an mRNA therapy for cardiometabolic diseases. Therapies using mRNA have a lot of potential as biologics. Leading Biotechs in the field include CureVac (interview with its CCO here) and […]

July 27, 2016 - 3 minutesmins - By Denise Neves Gameiro

liver hepatitis c gilead vaccine HCV metavax

News and Trends 27 Jul 2016

New Vaccine could solve the problem of the costly Gilead’s Hepatitis C ‘Cure’

Artes Biotechnology and Burnet Institute will join their proprietary technologies to develop a novel vaccine for the Hepatitis C virus. This could create a more affordable solution to reduce the high HCV-related mortality. Hepatitis C remains a health problem around the world. WHO estimates that more than half a million people die every year from […]

July 27, 2016 - 3 minutesmins - By Denise Neves Gameiro

biobased economy eu greentech ibbess interview biotechnology electricity plant green startup barcelona

News and Trends 26 Jul 2016

Be part of the European BioEconomy! Here are 3 Dutch GreenTech Events this Year

Here are 3 events to kickstart your greentech career. As Europe works towards a bioeconomy, challenges like these offer the opportunity to get involved and make Green ideas come to life. Put together by the students from Wageningen University, here are several bioeconomy and sustainability challenges for you to solve before the end of 2016. Maybe this could be a […]

July 26, 2016 - 4 minutesmins - By Dani Bancroft

why lithuania biotech baltic life sciences

News and Trends 26 Jul 2016

What is Lithuania’s role in European Biotech?

Since the days of the Soviet Union, Lithuania has always been considered as a leader in life sciences discoveries in Eastern Europe due to its infrastructure. But what about for Biotech? Nowadays, as a member of the NATO, the European Union, and Eurozone, Lithuania’s life science sector is growing around 20-25% annually; with special focus on […]

July 26, 2016 - 2 minutesmins - By Dani Bancroft

cancer hypoxia antimalarial drug atovaquone

News and Trends 26 Jul 2016

This Malaria drug is being re-purposed for Cancer Radiotherapy

Cancer Research UK says an old anti-malaria drug could be repurposed as a cancer therapy. In pre-clinical studies, this drug increases oxygen levels in tumors, making them easier to treat with radiotherapy. Atovaquone has been on the market since 2000 as part of an anti-malarial drug. It is also commercialized by GSK under the name Mepron for […]

July 26, 2016 - 3 minutesmins - By Denise Neves Gameiro

micreos eczema mrsa infection dermatitis antibiotic biotech

News and Trends 25 Jul 2016

Eczema could also be caused by Superbugs, so how could this Biotech fight it?

A new study has shown that on average, 70% of eczema patients are colonised with Staphylococcus aureus bacteria on their skin lesions (which include MRSA). Could this the Dutch biotech Micreos therefore have the solution to preventing spread of antibiotic-resistant strains in Eczema patients? Atopic dermatitis (eczema) is an extremely common skin affliction which can cause in painful lesions, […]

July 25, 2016 - 3 minutesmins - By Dani Bancroft

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Polish Selvita’s Inflammation Research used to start new Biotech in Scotland

Philogen targets Angiogenesis for cancer and Autoimmune Therapies

World Hepatitis Day 2016: What is the plan for Biotech and Policy Makers?

Pocket NGS can now select DNA fragments for faster Sequencing

World first Drug to ‘dissolve’ Tau-tangles in Alzheimer’s has Phase III Results

SynBio Nootkatone now in trials to stop the Spread of Zika

AstraZeneca plans Phase I trial with mRNA therapy for Cardiovascular Disease

New Vaccine could solve the problem of the costly Gilead’s Hepatitis C ‘Cure’

Be part of the European BioEconomy! Here are 3 Dutch GreenTech Events this Year

What is Lithuania’s role in European Biotech?

This Malaria drug is being re-purposed for Cancer Radiotherapy

Eczema could also be caused by Superbugs, so how could this Biotech fight it?

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!